LVCLF

Algorae Pharmaceuticals Limited

USD

Set alert

Price alert · LVCLF

All alert types
0.01 USD 0.00 0.00%
As of Oct 29, 2026
0.0035 Day range 0.0035
0.0035 52-week range 0.00955
YTD
+20.89%
1 year
+51.59%
Open
0.0035
Prev close
0.00955
Mkt cap
19.36M
Vol
40.00K
Avg vol
0
EPS
0.00
P/E
0.00
More statistics
Low
0.0035
High
0.0035

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for LVCLF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

7.14 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

D+1 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -9.2×
FY 2017: -14.4×FY 2018: -43.9×FY 2019: -5.4×FY 2020: -8.1×FY 2021: -5.0×FY 2022: -4.6×FY 2023: -8.6×FY 2024: -8.0×FY 2025: -16.4×FY 2026: -9.2×
FY 2017 5y median -8.6× FY 2026
P/S 0.0×
FY 2017: 515×FY 2018: 131×FY 2019: 1779×FY 2020: 2492×FY 2021: 27.1×FY 2022: 2640×FY 2023: 443×FY 2024: 133×FY 2025: 0.0×FY 2026: 0.0×
FY 2017 5y median 133× FY 2026
P/B 5.8×
FY 2017: 7.9×FY 2018: 2.2×FY 2019: 4.2×FY 2020: 2.7×FY 2021: 5.3×FY 2022: 2.2×FY 2023: 4.9×FY 2024: 5.5×FY 2025: 5.9×FY 2026: 5.8×
FY 2017 5y median 5.5× FY 2026
P/FCF -9.1×
FY 2017: -16.4×FY 2018: -4.5×FY 2019: -8.5×FY 2020: -2.5×FY 2021: -5.0×FY 2022: -4.4×FY 2023: -9.4×FY 2024: -11.0×FY 2025: -16819×FY 2026: -9.1×
FY 2017 5y median -9.4× FY 2026
EV/EBITDA -6.5×
FY 2017: -10.0×FY 2018: -2.2×FY 2019: -3.0×FY 2020: -1.7×FY 2021: -4.4×FY 2022: -3.3×FY 2023: -9.5×FY 2024: -8.6×FY 2025: 0.0×FY 2026: -6.5×
FY 2017 5y median -6.5× FY 2026
EV/Sales 0.0×
FY 2017: 450×FY 2018: 74.8×FY 2019: 1277×FY 2020: 1636×FY 2021: 21.2×FY 2022: 1395×FY 2023: 345×FY 2024: 109×FY 2025: 0.0×FY 2026: 0.0×
FY 2017 5y median 109× FY 2026
FCF Yield -11.0%
FY 2017: -6.1%FY 2018: -22.4%FY 2019: -11.8%FY 2020: -39.4%FY 2021: -20.1%FY 2022: -22.8%FY 2023: -10.7%FY 2024: -9.1%FY 2025: -0.0%FY 2026: -11.0%
FY 2017 5y median -10.7% FY 2026

Profitability

Gross Margin 0.0%
FY 2017: 100.0%FY 2018: 100.0%FY 2019: 100.0%FY 2020: 100.0%FY 2021: 81.6%FY 2022: 78.2%FY 2023: 98.7%FY 2024: 100.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 78.2% FY 2026
Operating Margin 0.0%
FY 2017: -4556.3%FY 2018: -3517.8%FY 2019: -42607.5%FY 2020: -99835.9%FY 2021: -749.7%FY 2022: -70042.7%FY 2023: -4968.3%FY 2024: -1659.5%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median -1659.5% FY 2026
Net Margin 0.0%
FY 2017: -3548.1%FY 2018: -308.5%FY 2019: -32565.9%FY 2020: -30570.4%FY 2021: -544.6%FY 2022: -57483.1%FY 2023: -5016.3%FY 2024: -1673.8%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median -1673.8% FY 2026
ROE -66.0%
FY 2017: -54.4%FY 2018: -5.2%FY 2019: -76.9%FY 2020: -33.6%FY 2021: -106.1%FY 2022: -48.5%FY 2023: -56.0%FY 2024: -69.5%FY 2025: -36.0%FY 2026: -66.0%
FY 2017 5y median -56.0% FY 2026
ROIC -67.0%
FY 2017: -67.7%FY 2018: -38.9%FY 2019: -92.0%FY 2020: -72.7%FY 2021: -111.9%FY 2022: -48.8%FY 2023: -55.5%FY 2024: -68.9%FY 2025: -69.8%FY 2026: -67.0%
FY 2017 5y median -67.0% FY 2026
ROA -63.4%
FY 2017: -47.0%FY 2018: -4.9%FY 2019: -55.2%FY 2020: -28.6%FY 2021: -88.9%FY 2022: -45.8%FY 2023: -50.0%FY 2024: -65.6%FY 2025: -33.5%FY 2026: -63.4%
FY 2017 5y median -50.0% FY 2026

Growth (YoY)

Revenue 0.0%
FY 2017: -4.0%FY 2018: 5.3%FY 2019: -92.0%FY 2020: -67.6%FY 2021: 8365.4%FY 2022: -98.7%FY 2023: 1134.0%FY 2024: 198.0%FY 2025: -100.0%FY 2026: 0.0%
FY 2017 FY 2026
Operating Income -109.3%
FY 2017: -30.1%FY 2018: 18.7%FY 2019: 2.5%FY 2020: 24.0%FY 2021: 36.4%FY 2022: -18.6%FY 2023: 12.5%FY 2024: 0.5%FY 2025: 25.1%FY 2026: -109.3%
FY 2017 FY 2026
EPS (diluted) -200.0%
FY 2017: -10.8%FY 2018: 91.7%FY 2019: -783.3%FY 2020: 69.8%FY 2021: -50.0%FY 2022: 8.3%FY 2023: 27.3%FY 2024: 18.8%FY 2025: 61.5%FY 2026: -200.0%
FY 2017 FY 2026
Free Cash Flow -343675.2%
FY 2017: -5.2%FY 2018: 1.3%FY 2019: 42.8%FY 2020: -52.2%FY 2021: 53.0%FY 2022: -40.0%FY 2023: 2.9%FY 2024: 23.3%FY 2025: 99.9%FY 2026: -343675.2%
FY 2017 FY 2026

Financial Health

Current Ratio 25.1×
FY 2017: 7.0×FY 2018: 15.1×FY 2019: 3.3×FY 2020: 9.9×FY 2021: 6.1×FY 2022: 17.8×FY 2023: 9.4×FY 2024: 17.9×FY 2025: 14.1×FY 2026: 25.1×
FY 2017 5y median 17.8× FY 2026
Quick Ratio 24.1×
FY 2017: 6.9×FY 2018: 15.1×FY 2019: 3.3×FY 2020: 9.9×FY 2021: 6.1×FY 2022: 17.8×FY 2023: 9.4×FY 2024: 17.9×FY 2025: 14.1×FY 2026: 24.1×
FY 2017 5y median 17.8× FY 2026
Debt / Equity 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.1×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×FY 2026: 0.0×
FY 2017 5y median 0.0× FY 2026
Net Debt / EBITDA 1.0×
FY 2017: 1.5×FY 2018: 1.6×FY 2019: 1.2×FY 2020: 0.9×FY 2021: 1.2×FY 2022: 2.9×FY 2023: 2.7×FY 2024: 2.0×FY 2025: 0.0×FY 2026: 1.0×
FY 2017 5y median 2.0× FY 2026
Interest Coverage 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×FY 2026: 0.0×
FY 2017 5y median 0.0× FY 2026

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026

Annual · latest fiscal year ends 2026-06-30